The influence of antileukotriene therapy with montelukast (M) on thromboxane B2 /leukotriene E4 (TXB2 /LTE4 ) ratio in the urine of asthmatic subjects and other inflammatory markers Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003
Thromboxane B2 and prostaglandin E2 concentrations in exhaled breath condensate in healthy volunteers and patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002
Measurement of prostaglandinE2 (PGE2 ) and thromboxaneB2 (TXB2 ) in exhaled breath condensate (EBC) in healthy volunteers Source: Eur Respir J 2002; 20: Suppl. 38, 510s Year: 2002
Aspirin significantly decreases urinary leukotriene E4 concentration in aspirin-tolerant asthma patients who show hyperleukotrienuria in stable condition Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
Prostaglandin D2 (PGD2 ) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
A metabolite of prostaglandin D2, 15-deoxy-?12,14-prostaglandin J2 (15d-PGJ2), in exhaled breath condensate (EBC) of asthma patients Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017
Urinary LTE4 (U-LTE4 ) level after systemic corticosteroid (CS) treatment Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
Comparison of leukotrienes in 3 matrices (EBC, blood and urine) in patients with pneumoconioses and control subjects Source: Annual Congress 2010 - Mineral dusts and respiratory disease Year: 2010
Imbalance of anti-inflammatory (resolving D1) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017
Plasma 6-ketoPGF1α, a stable metabolite of prostaglandin I2 shows a marked decrease in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006
Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum supernatant in smoking asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Prospective nitrite, nitrate and cys-leukotriene (cys-LTs ) measurements in EBC (exhaled breath condensate) in asthmatic children and relation to outcome during inhaled steroid (IS) reduction Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003
Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
Inhaled substance P, but not neurokinin A, enhances levels of alpha-2-macroglobulin in induced sputum of patients with mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 162s Year: 2001
Eosinophils from healthy children (1-3 years) and adults express high levels of prostaglandin D2 receptor 2 (DP2) Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018
Eicosanoid concentrations in induced sputum (IS) in stable asthmatics with aspirin-tolerant (ATA) and aspirin-intolerant asthma (AIA) Source: Eur Respir J 2005; 26: Suppl. 49, 575s Year: 2005
Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing Source: Eur Respir J 2006; 27: 944-950 Year: 2006
The contents of α1-acid glycoprotein (α1-AGP) and metabolites of nitric oxide (NO) in nasal lavage fluid (NLF) of patients with bronchial asthma (BA) and allergic rhinitis (AR) and house dust mites (HDM) exposure Source: Eur Respir J 2001; 18: Suppl. 33, 43s Year: 2001
Eicosanoid concentrations in induced sputum (IS) and exhaled breath condensate (EBC) in stable asthmatics with aspirin-tolerant (ATA) and aspirin-intolerant asthma (AIA) Source: Eur Respir J 2004; 24: Suppl. 48, 679s Year: 2004
Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001